Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
SUPPOSITORY
**Dosage and method of administration** Dosage 1-day treatment: 1 vaginal suppository (containing 600 mg isoconazole) is used as one single dose. Method of administration The ovulum must be inserted deep into the vagina. This is best done in the lying position in the evening before going to sleep. The enclosed finger stalls should be used to assist insertion. The treatment is not to be carried out during menstruation.
VAGINAL
Medical Information
**Indications** Gyno-Travogen suppository is indicated in fungal infections of the vagina including mixed infections with gram-positive bacteria.
**Contraindications** Hypersensitivity to the active substance or to any of the excipients.
G01AF07
isoconazole
Manufacturer Information
BAYER (SOUTH EAST ASIA) PTE LTD
BAYER DE MEXICO, S.A. DE C.V.
Active Ingredients
Documents
Package Inserts
GYNO-TRAVOGEN OVULE PI.pdf
Approved: December 27, 2021